Hello, welcome to Bioperfectus
For A Healthier Life
Dedicated to human health with a network covering more than 50 countries and regions.
A public listed company specialized in diagnostic solution of infectious diseases and many others.
BioPerfectus, a public listed company at Shanghai Stock Exchange (SSE:688399), is one of the leading molecular diagnostic solution providers in global in-vitro diagnostic market since 2010.
One of the leading molecular diagnostic solution providers in global in-vitro diagnostic market since 2010.
Bioperfectus is key real-time PCR product supplier for Chinese disease prevention and control market.
Company news and information of Jiangsu Bioperfectus Technology Co. Ltd..
Reach out to us and explore more of bioPerfectus.
We Bioperfectus would like to take this special moment to wish all of our Muslim communities a Happy Eid Al-Adha 2021.
With the ongoing COVID-19 variants rise across the globe, Bioperfectus sets out for testing in the post-pandemic era.
BfArM grants Bioperfectus special approval for COVID-19 antigen self-test
Copyright © 2010-2021 Jiangsu Bioperfectus Technologies Co., Ltd All Rights Reserved.